The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction.
暂无分享，去创建一个
U. Deuschle | M. Trauner | P. Schwabl | C. Kremoser | P. Starlinger | B. Podesser | G. Oberhuber | D. Mitteregger | T. Reiberger | M. Burnet | H. Hayden | N. Rohr-Udilova | E. Hambruch | M. Peck‐Radosavljevic | F. Riedl | Berit Seeland | Michael Wagner | L. Garnys | B. Strobel | Tim-Lukas Schubert | N. Rohr‐Udilova